Right to HealthTrade Policy Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthorityMarch 16, 2022 I'm happy to announce that my book, "Intellectual Property Law and Access to Medicines: TRIPS…Srividhya Ragavan COVID-19TRIPS Waive Intellectual Property Rights & Save LivesDecember 6, 2021 SouthViews no. 231 | 29 November 2021 | South Centre In October of 2020, when…Srividhya Ragavan PatentsRight to Health Expand the Study of Intellectual Property RightsSeptember 28, 2021 It should especially assess effects on health and productivity This article was published as an…Srividhya Ragavan COVID-19TRIPS Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and PharmaceuticalsAugust 4, 2021 Amaka Vanni and I are pleased to share our new book, Intellectual Property Law and…Srividhya Ragavan TRIPS An Open letter to the United States Trade Representative on the TRIPS WaiverMay 19, 2021 May 15, 2021 The Honorable Ambassador Katherine C. Tai United States Trade Representative Executive Office…Srividhya Ragavan TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19TRIPS Waive Intellectual Property Rights & Save LivesDecember 6, 2021 SouthViews no. 231 | 29 November 2021 | South Centre In October of 2020, when…Srividhya Ragavan PatentsRight to Health Expand the Study of Intellectual Property RightsSeptember 28, 2021 It should especially assess effects on health and productivity This article was published as an…Srividhya Ragavan COVID-19TRIPS Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and PharmaceuticalsAugust 4, 2021 Amaka Vanni and I are pleased to share our new book, Intellectual Property Law and…Srividhya Ragavan TRIPS An Open letter to the United States Trade Representative on the TRIPS WaiverMay 19, 2021 May 15, 2021 The Honorable Ambassador Katherine C. Tai United States Trade Representative Executive Office…Srividhya Ragavan TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
PatentsRight to Health Expand the Study of Intellectual Property RightsSeptember 28, 2021 It should especially assess effects on health and productivity This article was published as an…Srividhya Ragavan COVID-19TRIPS Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and PharmaceuticalsAugust 4, 2021 Amaka Vanni and I are pleased to share our new book, Intellectual Property Law and…Srividhya Ragavan TRIPS An Open letter to the United States Trade Representative on the TRIPS WaiverMay 19, 2021 May 15, 2021 The Honorable Ambassador Katherine C. Tai United States Trade Representative Executive Office…Srividhya Ragavan TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19TRIPS Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and PharmaceuticalsAugust 4, 2021 Amaka Vanni and I are pleased to share our new book, Intellectual Property Law and…Srividhya Ragavan TRIPS An Open letter to the United States Trade Representative on the TRIPS WaiverMay 19, 2021 May 15, 2021 The Honorable Ambassador Katherine C. Tai United States Trade Representative Executive Office…Srividhya Ragavan TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
TRIPS An Open letter to the United States Trade Representative on the TRIPS WaiverMay 19, 2021 May 15, 2021 The Honorable Ambassador Katherine C. Tai United States Trade Representative Executive Office…Srividhya Ragavan TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
TAMU Executive Education Program on Health, Pharmaceuticals and Intellectual PropertyAugust 28, 2020 Please join us for an Executive Education Program on Health, Pharmaceuticals and Intellectual Property, co-sponsored…Doris Estelle LongSrividhya Ragavan Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
IPAB India’s IPAB Denies Access To A Leukemia Medication In An Unsubstantiated IPAB Order And Creates UncertaintyJune 19, 2020 An interim order of the IPAB from Justice Manmohan Singh & Dr Onkar Nath ensures…Srividhya Ragavan COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan 1 2 Next